130 related articles for article (PubMed ID: 31263894)
41. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis.
Lee JH; Ahn BK; Baik SS; Lee KH
In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
[TBL] [Abstract][Full Text] [Related]
44. RAS status in Korean patients with stage III and IV colorectal cancer.
Lee WS; Lee JN; Baek JH; Park YH
Clin Transl Oncol; 2015 Sep; 17(9):751-6. PubMed ID: 25997687
[TBL] [Abstract][Full Text] [Related]
45. Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients.
Hamzehzadeh L; Khadangi F; Ghayoor Karimiani E; Pasdar A; Kerachian MA
Curr Probl Cancer; 2018 Nov; 42(6):572-581. PubMed ID: 29921458
[TBL] [Abstract][Full Text] [Related]
46. Roles of ARID1A variations in colorectal cancer: a collaborative review.
Zhao S; Wu W; Jiang Z; Tang F; Ding L; Xu W; Ruan L
Mol Med; 2022 Apr; 28(1):42. PubMed ID: 35421925
[TBL] [Abstract][Full Text] [Related]
47. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.
Calles A; Sholl LM; Rodig SJ; Pelton AK; Hornick JL; Butaney M; Lydon C; Dahlberg SE; Oxnard GR; Jackman DM; Jänne PA
Clin Cancer Res; 2015 Jun; 21(12):2851-60. PubMed ID: 25737507
[TBL] [Abstract][Full Text] [Related]
49. ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis.
Hung YP; Redig A; Hornick JL; Sholl LM
Mod Pathol; 2020 Nov; 33(11):2256-2268. PubMed ID: 32572156
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
51. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
52. Demographic trends and KRAS/BRAF
Fu X; Huang Y; Fan X; Deng Y; Liu H; Zou H; Wu P; Chen Z; Huang J; Wang J; Lin H; Huang S; Tan X; Lan P; Wang L; Wang JP
Int J Cancer; 2019 May; 144(9):2109-2117. PubMed ID: 30414169
[TBL] [Abstract][Full Text] [Related]
53. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
Li W; Qiu T; Guo L; Ying J
Cancer Lett; 2017 Dec; 410():92-99. PubMed ID: 28942013
[TBL] [Abstract][Full Text] [Related]
54. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
[TBL] [Abstract][Full Text] [Related]
55. TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.
Ando J; Saito M; Imai JI; Ito E; Yanagisawa Y; Honma R; Saito K; Tachibana K; Momma T; Ohki S; Ohtake T; Watanabe S; Waguri S; Kono K; Takenoshita S
Fukushima J Med Sci; 2017 Dec; 63(3):141-151. PubMed ID: 29199261
[TBL] [Abstract][Full Text] [Related]
56. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
57. Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis.
Chao A; Wu RC; Lin CY; Lee LY; Tsai CL; Lee YS; Wang CJ
J Obstet Gynaecol; 2023 Dec; 43(1):2161352. PubMed ID: 36708516
[TBL] [Abstract][Full Text] [Related]
58. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
[TBL] [Abstract][Full Text] [Related]
59. Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients.
Nishida T; Egashira Y; Akutagawa H; Fujii M; Uchiyama K; Shibayama Y; Hirose Y
Dis Colon Rectum; 2014 Aug; 57(8):905-15. PubMed ID: 25003285
[TBL] [Abstract][Full Text] [Related]
60. Challenging a dogma: co-mutations exist in MAPK pathway genes in colorectal cancer.
Grellety T; Gros A; Pedeutour F; Merlio JP; Duranton-Tanneur V; Italiano A; Soubeyran I
Virchows Arch; 2016 Oct; 469(4):459-64. PubMed ID: 27401719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]